Ayble Health

Ayble Health is a provider of an AI-enabled virtual multidisciplinary GI clinic. From its funding announcement.

$16M Series ARaised 45 days agoBoston, USAHealthcare & MedtechUSA

6companies raised yesterday 70raised in the last 7 days 22US expansion signals this month 25companies stated hiring plans this month 2039open roles

In their own words

What Ayble Health says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "provider of an AI-enabled virtual multidisciplinary GI clinic". Source

Market expansion

Public signal Read from the company's own description of what the funding supports.

Why now

Where Ayble Health is today

Ayble Health announced a Series A round of $16M on 16 September 2026, led by Neon.

Latest round

Series A

Amount

$16M

Announced

16 September 2026

Headquarters

Boston, USA

Sector

Healthcare & Medtech

Investors

Neon

Also participating

Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, Accomplice, individual

Relevant leadership

Founder and CEO Sam Jactel

Momentum AfterRaise intelligence

AfterRaise Score

Steady growth

1 funding signal in the last 90 days

Funding recency

34/40

announced within the last 60 days

Round scale

12/25

round size relative to the market

Funding stage

15/20

Series A

Funding cadence

0/15

one funding event tracked this year

Arriving with the signals layer

Hiring momentum Open roles and hiring pace
Market expansion New offices and new countries
Leadership Executive appointments
Product activity Launches and releases

Since the raise

What has happened since

16 September 2026
$16M Series A
Led by Neon.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

New market entry
First local hires in the new market
Local entity and legal setup
Repeatable go-to-market build

Opportunities this could create

Provider partnerships
Market-entry advisers
Local employment infrastructure
In-market partnerships
Clinical evidence

Based on the Healthcare & Medtech sector, a Series A round and the priorities the company itself set out. Not a statement of fact.

Medium momentum2 connected signals

16 September 2026$16M Series A announced
16 September 2026Stated priority: market expansion

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Ayble Health is open to

Not yet specified

Ayble Health has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Ayble Health is hiring for this role on its own job board, after raising $16M.

Who they want

Approach preferences not yet specified

Apply on Ayble Health’s site →Company page

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Ayble Health?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Claim your company profile Correct something

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving